These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 25501779

  • 1. A 15-year review of pediatric toxic epidermal necrolysis.
    Quirke KP, Beck A, Gamelli RL, Mosier MJ.
    J Burn Care Res; 2015; 36(1):130-6. PubMed ID: 25501779
    [Abstract] [Full Text] [Related]

  • 2. Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience.
    McCullough M, Burg M, Lin E, Peng D, Garner W.
    Burns; 2017 Feb; 43(1):200-205. PubMed ID: 27554629
    [Abstract] [Full Text] [Related]

  • 3. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
    Nizamoglu M, Ward JA, Frew Q, Gerrish H, Martin N, Shaw A, Barnes D, Shelly O, Philp B, El-Muttardi N, Dziewulski P.
    Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.
    Papp A, Sikora S, Evans M, Song D, Kirchhof M, Miliszewski M, Dutz J.
    Burns; 2018 Jun; 44(4):807-815. PubMed ID: 29627131
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
    Lim VM, Do A, Berger TG, Nguyen AH, DeWeese J, Malone JD, Jordan K, Hom F, Tuffanelli L, Fillari P, Siu S, Grossman R.
    Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical features and outcomes in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Chi MH, Chung WH, Hui RC, Chen CB, Lu CW, Chiu TM, Ma DH, Wang CW, Yang CY, Taiwan Severe Cutaneous Adverse Reaction Consortium.
    J Dermatol; 2022 Sep; 49(9):895-902. PubMed ID: 35715971
    [Abstract] [Full Text] [Related]

  • 12. The use of Biobrane® for wound coverage in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Rogers AD, Blackport E, Cartotto R.
    Burns; 2017 Nov; 43(7):1464-1472. PubMed ID: 28526303
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Genitourinary involvement and management in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Van Batavia JP, Chu DI, Long CJ, Jen M, Canning DA, Weiss DA.
    J Pediatr Urol; 2017 Oct; 13(5):490.e1-490.e7. PubMed ID: 28314701
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.